Bio Special
FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
The FDA’s recent decision to cut its workforce by 20 percent has raised concerns across the biopharma industry, with experts warning of inevitable de...
July 09, 2025 | Opinion | By Lindsay Mateo, Chief Commercial Officer at Weave Bio
Smarter Together: How Molecule GEN Transforms Cross-Functional Drug Discovery
This cloud-native, SaaS-based platform breaks down traditional barriers in drug discovery by uniting all disciplines—biology, chemistry, and computat...
July 07, 2025 | Opinion | By Saurabh Singal | CEO-Founder, Molecule AI
Southeast Asia Poised to Lead AI-Driven Healthcare Transformation Amid Rising Cross-Border Collaboration
The Southeast Asia (SEA) region’s role in healthcare innovation, long bolstered by Singapore’s commitment to serve as a g...
July 01, 2025 | Opinion | By Chu Canh Chieu, FPT Software Managing Director of Global Healthcare Center, FPT Corporation
India’s Life Sciences Industry Faces a Defining Moment Amid Shifting U.S. Drug Policies and Regulatory Scrutiny
India’s life sciences industry has grown at a remarkable pace over the past two decades, transforming into a global manufacturing powerhouse. Indian ...
June 25, 2025 | Opinion | By Sidley Austin partners Arif S. Noorani and Ryan Tan
ASCO 2025 Showcases New Oncology Paradigms, From Breast Cancer Breakthroughs to AI-Led Precision Medicine
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting wasn’t just another scientific gathering and it was a seismic event that redrew ...
June 06, 2025 | Report
Quadria Capital Closes Oversubscribed $1.07B Fund III to Drive Healthcare Innovation Across India and Southeast Asia
Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia heal...
May 27, 2025 | News
Closer to Customers, Stronger in Supply: Oliver’s APAC Leader on Malaysia Facility and Future Plans
In a move that underscores its long-term commitment to the Asia-Pacific region, Oliver Healthcare Packaging has inaugurated a new...
May 23, 2025 | Interview
Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia
In this interview with BioPharma APAC, Christophe Meugnier, Chief Commercial Officer and General Manager of Vietnam & Thailand at Do...
May 19, 2025 | Interview
Streamlining Biologics QC: How Waters’ Empower-MALS Integration Is Reshaping Analytical Workflows
Waters Corporation is tackling the complexity of biologics quality control with the integration of Multi-Angle Light Scattering (MALS) into its Empower&tr...
May 16, 2025 | Interaction
Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...
May 09, 2025 | Expert Insight
Rege Nephro Acquires Tamibarotene Assets from Syros Pharmaceuticals to Advance ADPKD Program
Rege Nephro Co., Ltd. (Headquarter: Kyoto, Japan; Chief Executive Officer: Akifumi Morinaka) has announced that it has successfully acquired Tami...
April 16, 2025 | News
How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
In this exclusive email interaction with BioPharma APAC, Alessandra Ambruosi, Director & Head of Solid Formulations & Pharm Materia...
April 02, 2025 | Interview
Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...
March 14, 2025 | Interaction
AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Chronic kidney disease (CKD) is a growing public health challenge in Asia, affecting over 400 million people. In an insightful discussion with BioPharma AP...
March 12, 2025 | News
Most Read
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
